Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts by unknown
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Lipopolysaccharide (LPS) is a major component of the outer membrane of
Gram-negative bacteria including Escherichia, Salmonella, Shigella, Pseudomo-
nas, and numerous other genera (1, 2). LPS triggers many of the deleterious
effects of bacterial infections in animals (1, 2). For example, endotoxemic shock
represents the intravascular activation by LPS of the coagulation cascade, the
complement system, and the bradykinin system; these events lead to a collapse
of the cardiovascular system (1, 2). Host immune mechanisms recognize LPS
and respond to its presence by activation of macrophages (3). LPS-activated
macrophages secrete a variety of important cytokines such as IL-1, TNF, and
lymphotoxin, which play key roles in host defense (4-8). In this article we
describe another component in the host response elicited by LPS. We report
that the fibroblast, a type of cell present in all body tissues, responds to LPS by
secreting IFN-02. IFN-N2 polypeptides have been reported to elicit an antiviral
state in fibroblasts, increase immunoglobulin secretion by certain B cell lines,
enhance proliferation of plasmacytoma/hybridoma cells, and mediate many of
the acute-phase alterations in the secretion ofplasma proteins by hepatocytes (9,
10). Taken together, the data obtained suggest that the ubiquitous fibroblast
may have a specific role in host defense during the course of Gram-negative
bacterial infections.
Human IFN-,Q2 comprises a set of at least six proteins ofM, 23,000-30,000,
asjudged by SDS-PAGE (reviewed in reference9 and L. T. May etal., manuscript
in preparation) and is derived from a gene on human chromosome 7 (11). IFN-
#2 cDNA has been cloned, sequenced, and expressed into biologically active
protein in heterologous expression systems (12-16). IFN-a2 is produced in a
variety of tissues comprising fibroblasts, epithelial cells, monocytes, and T cells
(9). The IFN-,B2 gene is identical to that for the B cell differentiation factor BSF-
2, the hybridoma growth factor HGF, and the hepatocyte-stimulating factor HSF
(9, 10). It is evident that IFN-#2 is engaged in multidirectional communication
among different cell types.
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Materials and Methods
Cell Culture.
￿
The human foreskin fibroblast strain FS-4 was obtained from Dr. J.
Vilcek (New York University School of Medicine, New York); procedures for its growth
in cell culture and for the IFN-#2 mRNA induction experiments have been described (15,
17).
RNA Blot-hybridization Analyses.
￿
Procedures for isolation of poly(A)' RNA from FS-4
cells (approximate RNA yield 1 Fag per T-175 culture), electrophoresis ofthe RNA in 1
agarose gels containing 10 mM methylmercury hydroxide, transfer to aminobenzyloxy-
methyl cellulose paper (ABM paper; Pharmacia Fine Chemicals, Piscataway, NJ), and
hybridization with full-length human IFN-fl, and -N2 cDNA clones have been described
(15, 17).
Assayfor Antiviral Activity.
￿
These were carried out essentially as described by Sehgal
et al. (17). Briefly, FS-4 cells were seeded in 96-well microtiter plates in Eagle's MEM
supplemented with 5% (vol/vol) heat-inactivated FCS (56°C for 0 .5 h; Gibco, Grand
Island, NY) to produce confluent monolayers. 6-8 d later the culture medium was
discarded and the monolayers were exposed to 100-,1 aliquots offresh medium containing
serial two-fold dilutions of the test samples. After incubation for 24 h, the monolayers
were challenged with vesicular stomatitis virus (VSV)' (Indiana strain, 10-100 plaque
forming units [PFU]/well) such that it produced complete destruction of control FS-4 cell
sheets 3-4 d after challenge. 4 d after addition of VSV, the cell monolayers were fixed
with ethanol and stained using Gram's crystal violet. Antiviral assays were calibrated using
appropriate human IFN-/4, standards.
Assayfor Enhancement of B Cell Differentiation.
￿
The CESS line of human B lympho-
blastoid cells (TIB190 ; American Type Culture Collection, Rockville, MD) was grown in
RPMI 1640 medium (Flow Laboratories, McLean, VA) supplemented with 10% (vol/vol)
heat-inactivated FCS (Hazelton Systems, Inc., Aberdeen, MD) and 2 mM glutamine
(Gibco). The ability of various dilutions of FS-4 cell culture medium to enhance differ-
entiation of 10" CESS cells after 60 h of incubation in 0.2 ml of medium in 96-well
microtiter plates (Linbro Chemical Co., Hamden, CT) was determined in triplicate using
a reverse plaque-forming cell (PFC) hemolytic assay, which detects the ability ofindividual
differentiated CESS cells to secrete human immunoglobulin IgG (18, 20-22). This assay,
which detects lysis of protein A-coupled sheep erythrocytes in the vicinity of each
immunoglobulin-secreting CESS cell, has been described in detail elsewhere (18, 20-22).
It monitors the differentiation of CESS cells from an IgG-nonsecreting phenotype to an
IgG-secreting phenotype.
Reagents.
￿
All LPS preparations, cycloheximide, and dexamethasone were purchased
from Sigma Chemical Co., St. Louis, MO. The compounds H7 and H8 were purchased
from Seikagaku America, St. Petersberg, FL. Recombinant E. coli-derived human IL-la
(sp act 3 X 107 U/mg) was a gift from Hoffman-LaRoche, Nutley, NJ, and recombinant
E. coli-derived human TNF (sp act 4 .8 X 107 U/mg) was a gift from The Suntory Institute
for Biomedical Research, Osaka, Japan, and, recombinant E. coli-derived IFN-,B, was a
gift from Triton Biosciences, Inc., Alameda, CA. Gram's crystal violet was purchased
from Fisher Scientific, Orangeburg, NY; a-[s2P]dCTP used for nick translation ofplasmid
DNA was purchased from New England Nuclear, Boston, MA. Autoradiography was
performed at -70°C using Kodak XAR-5 film and intensifying screens (Quanta III;
DuPont Co., Wilmington, DE).
Results and Discussion
Antiviral Activity of Bacterial LPS in Human Fibroblasts.
￿
In the course of
experiments to express human IFN-N2 in E. coli we observed that an aqueous
extract of E. coli could itself induce an antiviral state in human fibroblasts (FS-4
strain) against VSV (Fig. 1). LPS derived from E. coli also elicited an antiviral
' Abbreviations used in this paper:
￿
HSF, hepatocyte-stimulating factor; PFC, plaque-forming cell ;
VSV, vesicular stomatitisvirus.1302
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FIGURE 1 .
￿
Inhibition of the cytopathic effect of VSV in fibroblasts incubated with E . coli-
derived LPS . FS-4 cells were seeded in 96-well microtiter plates to produce confluent mono-
layers . 6 d later the culture medium was discarded and the monolayers were exposed to 100
ul aliquots offresh medium containing serial twofold dilutions (from left to right in the figure)
of a recombinant IFN-0, preparation (titer 100 IU/ml), a preparation of phenol-extracted
LPS derived from E . coli serotype 0111 :114 (highest concentration tested was 1 ug/ml), or an
extract of E. coli strain HB10I (prepared by sedimenting bacteria from a 5 ml log-phase
culture, subjecting the pellet to a freeze-thaw cycle, followed by resuspension in 0.5 ml water,
sonication, and Millipore filtration [0.22 ,um]). After incubation for 24 h, the monolayers were
challenged with VSV . 4 d after addition ofVSV, the cell monolayers were fixed with ethanol
and stained using the crystal violet . Dark-stained monolayers are those that have been protected
from virus-mediated cell killing .
state (Fig. 1) . This represents a rediscovery of the antiviral effect of LPS in cell
culture. Likar et al . (23) reported in 1959 thatE . coli and Salmonella typhimurium
endotoxin inhibited poliovirus replication in secondary monkey kidney cells .
That a bacterial constituent can have an inhibitory effect on viral multiplication
was first demonstrated with the capsular polysaccharide of Klebsiella pneumoniae
and the pneumonia virus of mice and the mumps virus (24-26) . In the 1960s a
number of reports documented the antiviral effects of constituents of Gram-
negative as well as Gram-positive bacteria in cultures of fibroblasts or epithelial
cells (27-32). As the inhibitory substances from the Gram-positive bacteria had
a narrow range of antiviral activity (27-29), it appeared unlikely that their action
was mediated via the production of endogenous IFN . It is, however, of interestHELFGOTT ET AL .
￿
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FIGURE 2 .
￿
Inductionof IFN-02mRNA in fibroblasts
by an extract of E. coli (a) or by E. coli-derived LPS
(b) . Confluentmonolayers ofFS-4 cells in T-175 flasks
(one flask per group) were exposed for 6-7 h to a
1 :10 dilution of a pool of E . coli extracts prepared
essentiallyas mentioned in Fig. 1 (sonication was omit-
ted) or to LPS at different concentrations (E. coli,
serotype 0111 :134) . The E. coli extract was a pool of
samples that displayed antiviral activity at dilutions in the range from 1:2 to 1 :8 . The levels of IFN-
02 mRNA were monitored by agarose gel electrophoresis followed by blot hybridization using a full-
length human IFN-02cDNA probe . The region of the autoradiogram containing the 1 .3 kb IFN-02
mRNA is illustrated. a : lane 1, control ; lane 2, E. coli extract. b: lane 1, control ; lane 2, LPS, 1 ug/ml;
lane 3, 100 ng/ml ; lane 4, 10 ng/ml ; lane 5, 1 ng/ml ; lane 6, 0.3 ng/ml; lane 7, 0.1 ng/ml .
FIGURE 3 .
￿
Rapid enhancement of IFN-02 mRNA levels in fibro-
blasts by LPS . Confluent monolayers of FS-4 cells in T-175 flasks
(one flask per group) were exposed to LPS (E. coli, serotype
0111 :114, 5 wg/ml) for the following periods : lane 1, 0 min ; lane 2,
15 min ; lane 3, 30 min; lane ~4, 45 min ; lane 5, 1 h ; lane 6, 2h; lane
7, 3 h . The content of IFN-I'2 mRNA was assayed by blot hybridi-
zation .
that actinomycin D inhibited the development of the antiviral state elicited by
an E. coli extract (32) .
Induction ofIFN-(32mRNA by Bacterial LPS inHuman Fibroblasts.
￿
We observed
that the antiviral activity ofLPS in FS-4 cells could be completely blocked by an
anti-IFN-,B antiserum (not shown), thus implicating the induction ofendogenous
IFN-,B by LPS in the development of the antiviral state . Using blot-hybridization
methods we determined that extracts of E . coli or LPS prepared from E. coli
enhanced the levels of IFN-02 mRNA in FS-4 cells (Fig . 2) . It should be
emphasized that LPS did not induce detectable levels of IFN-,E, mRNA (not
shown) .
LPS enhances IFN-02 mRNA levels in FS-4 cells at concentrations as low as
0.3 ng/ml (Fig . 2B, lane 6) . The enhancement is near-maximal at an LPS
concentration in the range 0.1-1 jAg/ml (Fig . 2B) . The enhancement is rapid ; an
increase is detected within 30 min after addition of LPS, and is near-maximal by
2-3 h (Fig . 3) . The increase is sustained at this high level for at least 20 h
thereafter (not shown) .
The enhancementofIFN-02 gene expression in FS-4 cells by LPS is moderately
inhibited by 50 jM H8, a preferential inhibitor ofcAMP- and cGMP-dependent
protein kinases compared with protein kinase C (33), but is strongly inhibited by
50 uM H7, an inhibitor of protein kinase C as well as of cyclic nucleotide-
dependent protein kinases (33) (Fig . 4A). These observations are consistent with
the possibility that LPS enhances IFN-02 gene expression in fibroblasts by
activating the protein kinase C signal transduction pathway. Evidence has been
obtained in some, but not all studies of the involvement of protein kinase C in
the activation of resting murine B lymphocytes by LPS (34-36). It is noteworthy
that H7, but not H8, efficiently blocks IFN-02 gene expression in fibroblasts
treated with IL-1 or TNF (Fig . 4B) (17) .
LPS increased the levels of IFN-02 mRNA in FS-4 cells in the presence of
cycloheximide, indicating that new protein synthesis is not required for this1304
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FIGURE 4 .
￿
Effect of protein kinase
inhibitors H7 and H8 q on the induc-
tion by LPS of IFN-#2 mRNA in fi-
broblasts . Confluent monolayers of
FS-4 cells (one T-175 flask per
group) were incubated for 6 h with
LPS (1 ug/ml) alone or together with
the protein kinase inhibitors H7 (50
q
￿
uM)orH8 (50 uM). For comparison,
the effect of H7 on the inductionof IFN-N2 by IL-la (I ng/ml) and TNF(30ng/ml) is also illustrated .
a : lane 1, control ; lane 2, LPS ; lane 3, LPS and H7 ; lane 4, LPS and H8 . b : lane 1, control; lane 2,
LPS; lane 3, LPS and qH7 ; lane 4, IL-la; lane 5, IL-la and H7 ; lane 6, TNF; lane 7, TNF and H7 .
The content of IFN-N2 mRNA wasmeasured by blot hybridization .
FIGURE 5 .
￿
Effect of cycloheximide and dexamethasone
on the induction by LPS of IFN-#2 mRNA in fibroblasts .
Confluent monolayers of FS-4 cells (one T-175 flask per
group) were incubated for6 has follows : lane 1, control;
lane 2, LPS(10 jug/ml) ;lane 3, cycloheximide (50 ug/ml) ;
lane 4, LPS and cycloheximide ; lane 5, dexamethasone,
10-e M; lane 6, LPS and dexamethasone (10-e M) ; lane
7, LPS and dexamethasone (10'7 M) ; lane 8, LP qS and
dexamethasone (10-8 M) . The content of IFN-#2 was
assayed by blot hybridization .
FIGURE 6 .
￿
Enhancement of IFN-#2 mRNA levels in
fibroblasts by different preparations of bacterial LPS .
Confluent monolayers of FS-4 cells (one flask per
group) were treated for 6 h with different LPS (5
ug/ml) preparations as follows : lane 1, control; lanes
2-5, phenol-extracted LPS from E. coli serotype
0111 :114 (lane 2), serotype 055:115 (lane 3), serotype
026:116 (lane 4), and S . typhimurium (lane 5) ; lanes 6-
8, phenol-extracted and chromatographically purified
LPS from E. coli serotype 0111 :B4 (lane 6), serotype
055:115 (lane 7), and serotype 0026:116 (lane 8) . The
content of IFN-02 mRNA was assayed by blot hybrid-
ization .
induction (Fig . 5, lanes 1-4) . A combination of LPS and cycloheximide "super-
induces" the expression of IFN-N2 mRNA (Fig . 4, lane 4) (37, 38) . Of special
interest is the fact that the induction of IFN-#2 mRNA by LPS is inhibited by
dexamethasone (Fig . 5B, lanes 6-8), a glucocorticoid that also inhibits the
induction, in FS-4 cells, ofIFN-02mRNA by IL-1 andTNF (39) . Dexamethasone
may affect a common element in the signal transduction pathways used by the
three reagents . It has been suggested that dexamethasone inhibits some step
proximal to the formation of second messengers through the agonist-induced
hydrolysis of inositol phospholipids in LPS-stimulated murine B cells (40) .
The enhancement ofIFN-R2mRNA levels in FS-4 cells is a property of several
different LPS preparations . Chromatographically purified LPS derived from
three different strains of E. coli, as well as LPS derived from a strain of S.
typhimurium enhance IFN-R2 mRNA levels (Fig . 6) .
B Cell Differentiation Activity of Conditioned Medium from LPS-treated Fibroblast
Cultures . One of the immunologic consequences of IFN-#2 secreted by LPS-
treated fibroblasts is illustrated in Table 1 . FS-4 cells were treated with LPS for
6 h and then incubated in LPS-free medium for another 24 h . The cultureTABLE I
E. coli-derived LPS Stimulates Production ofIFN-N2 by Human Fibroblasts
(FS-4 Strain): EnhancementofB Cell (CESS) Differentiation
Additionsto CESS cells
HELFGOTT ET AL.
A. Culturemedium from FS-4 cells treated with:
Uninduced
LPS(1 jig/ml)
LPS(0.1 ug/ml)
TNF(30 ng/ml) + CHX (50 jcg/ml)
B.
PFC/culture when FS-4
cell culture medium was
added to CESS cellsat
dilutions of.
Confluent monolayers of FS-4 cells in T-175 flasks containing 10 ml of spent
medium were treated for 6 h with LPS at 1 or 0.1 wg/ml or with TNF (30
ng/ml) and cycloheximide (CHX, 50 ug/ml). The cultures were then washed
extensively with PBS and incubated in another 10 ml of spent medium per
flask. Culture medium was harvested 24 h later, cell debris removed by
centrifugation, andappropriate aliquots stored at -70°C .Theability ofvarious
dilutions of FS-4 cell culture medium to enhance differentiation of 10' CESS
cellsafter 60 h of incubation in 0.2 ml of medium in 96-well microtiter plates
was determined in triplicate usinga reverse PFChemolytic assay. As controls,
S. aureus Cowan I antigen (0.01%,vol/vol; BehringDiagnostics) or E. coli LPS
(1 Ag/ml) was added directly to the CESS cells. Saturating amounts of B cell
differentiation factor activity appear to be present in the 1:8 dilution of the
medium samplesfrom inducedFS-4 cell cultures;at the 1:100 dilution a lesser
amount of activity is observed.
* Mean of six experiments.
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medium obtained from LPS-treated FS-4 cells was then tested for its ability to
stimulate differentiation (immunoglobulin secretion) by an Epstein-Barr virus-
transformed human B cell line (CESS) (18, 19). It is clear from Table I that LPS-
treated FS-4 cells produce a cytokine that increases the number of IgG-secreting
CESS cells. Treatment of FS-4 cells with LPS or TNF at maximally effective
concentrations yielded culture media that caused comparable increases in the
number of IgG-secreting CESS cells (Table I).
Fibroblasts are not the only kinds of cells that secrete IFN-N2 when exposed to
LPS. It is known that human monocytes exposed to LPS secrete a protein called
the hepatocyte-stimulating factor (HSF) that alters the expression of plasma
protein genes in the liver (41-49). For example, HSF decreases the synthesis of
albumin and increases the synthesis of fibrinogen, haptoglobin, a2-macroglobu-
lin, and C-reactive protein. The alterations in liver gene expression constitute
the acute-phase response that occurs in acute bacterial or mycoplasma infections,
and tissue damage and is elicited by HSF as well as IL-1 (41-49). However, HSF
and IL-1 elicit qualitatively and quantitatively different responses in the expres-
sion of plasma protein genes (41-49). It has recently been shown that HSF and
IFN-(32 are the same molecule (10).
1:2 1:8 1:100
112 125 30
218 277 168
173 292 123
147 336 232
PFC/culture
Controls
S. aureus Cowan I antigen (0.01% vol/vol) 200
LPS(1 jug/ml) 66
None 77*1306
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The acute-phase response mediated via the action of monocyte-derived IFN-
,d2/HSF on the liver leads to systemic effects on the organism. In contrast, the
fibroblast-derived IFN-02 may primarily give rise to effects of local importance.
The ubiquitous fibroblasts play a key role in post-injury repair. LPS at concen-
trations in the range of 0.1 ng/ml to 5,ug/ml stimulates the proliferation of chick
embryo, murine, bovine, and human fibroblasts (including FS-4 cells) (50-53).
Production of IFN-02 by fibroblasts exposed to LPS is consistent with the
hypothesis that IFN-02 is part of an homeostatic mechanism that regulates
fibroblast proliferation (37, 38). The IFN-02 secreted by LPS-stimulated fibro-
blasts may enhance in situ immunoglobulin secretion by B lymphocytes. Addi-
tional evidence for a role of IFN-02 in the pathophysiology of acute infections is
provided by the findings of strong enhancement of IFN-02 gene expression in
fibroblasts during virus infections (54 and D. C. Helfgott and P. B. Sehgal,
unpublished data).
Summary
The human ,d2 interferon (IFN-R2) gene, a gene that also codes for B cell
differentiation factor 2 (BSF-2), plasmacytoma/hybridoma growth factor (HGF),
and hepatocyte-stimulating factor (HSF), is expressed in a variety of lymphoid
and nonlymphoid tissues. Endotoxin, or bacterial lipopolysaccharide (LPS) prep-
arations derived from the outer membrane of Escherichia coli or Salmonella
typhimurium rapidly elevate IFN-02 mRNA level in human skin fibroblasts (FS-4
strain). E. coli-derived LPS enhances IFN-02 mRNA expression in FS-4 fibro-
blasts at a concentration as low as 0.3 ng/ml; this response is near-maximal in
the range of 0.1-1 lig/ml LPS. The increase in IFN-02 mRNA level caused by
LPS in FS-4 cells is detected within 30 min after addition of LPS, is sustained
for at least 20 h thereafter, appears to involve the protein kinase C signal
transduction pathway, does not require new protein synthesis, and is inhibited
by dexamethasone in a dose-dependent fashion (in the range 10-s-10-8 M).
Cultures of LPS-treated FS-4 cells exhibit an antiviral state against vesicular
stomatitis virus, which can be prevented by anti-IFN-fl antiserum. Medium
obtained from LPS-treated FS-4 cell cultures enhances the number of immuno-
globulin-secreting cells in cultures of human B-lymphoblastoid (CESS) cells.
Thus, LPS may trigger a number of host defense mechanisms in the course of
infection due to Gram-negative bacteria by enhancing IFN-02 production by the
ubiquitous fibroblast.
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